The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II.

Wendy A DavisDavid G BruceMilan DragovicTimothy M E DavisSergio E Starkstein

Published in: PloS one (2018)

The DADS has strong psychometric validity in the identification of mixed depression-anxiety in type 2 diabetes, and may contribute to cardiovascular risk prediction.

Keyphrases

type diabetes
phase ii
sleep quality
glycemic control
cardiovascular disease
clinical trial
depressive symptoms
open label
insulin resistance
physical activity
phase iii
adipose tissue
placebo controlled
weight loss
double blind
bioinformatics analysis
study protocol